{
  "ticker": "VCEL",
  "company_name": "Vericel Corporation",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT01670981",
      "title": "An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections to Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Ischemic Dilated Cardiomyopathy (IDCM)",
      "start_date": "2013-02-20",
      "completion_date": "2018-03-07",
      "enrollment": 0,
      "sponsor": "Vericel Corporation"
    },
    {
      "nct_id": "NCT00719576",
      "title": "Superiority of MACI\u00ae Versus Microfracture Treatment in Patients With Symptomatic Articular Cartilage Defects in the Knee",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Articular Cartilage Defect",
      "start_date": "2008-07",
      "completion_date": "2012-03",
      "enrollment": 0,
      "sponsor": "Vericel Corporation"
    },
    {
      "nct_id": "NCT00158613",
      "title": "Study of the Treatment of Articular Repair (STAR)",
      "status": "COMPLETED",
      "phase": "PHASE4",
      "condition": "Articular Cartilage",
      "start_date": "2000-03",
      "completion_date": "2005-11",
      "enrollment": 0,
      "sponsor": "Vericel Corporation"
    },
    {
      "nct_id": "NCT00755911",
      "title": "Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Alveolar Bone Loss",
      "start_date": "2008-06",
      "completion_date": "2012-05",
      "enrollment": 0,
      "sponsor": "University of Michigan"
    },
    {
      "nct_id": "NCT00505219",
      "title": "Ixmyelocel-T Treatment of Patients With Osteonecrosis of the Femoral Head",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Osteonecrosis",
      "start_date": "2007-09",
      "completion_date": "2010-12",
      "enrollment": 0,
      "sponsor": "Vericel Corporation"
    },
    {
      "nct_id": "NCT01483898",
      "title": "An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI)",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Critical Limb Ischemia",
      "start_date": "2012-02",
      "completion_date": "2014-03-25",
      "enrollment": 0,
      "sponsor": "Vericel Corporation"
    },
    {
      "nct_id": "NCT00424567",
      "title": "Feasibility Study of Aastrom Tissue Repair Cells to Treat Non-Union Fractures.",
      "status": "TERMINATED",
      "phase": "PHASE1, PHASE2",
      "condition": "Fracture, Ununited, Pseudarthrosis",
      "start_date": "2003-10",
      "completion_date": "2007-06",
      "enrollment": 0,
      "sponsor": "Vericel Corporation"
    },
    {
      "nct_id": "NCT01251588",
      "title": "Extension Study for Participants of MACI00206 Study of MACI\u00ae for the Treatment of Symptomatic Articular Cartilage Defects of the Knee",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Articular Cartilage Defects",
      "start_date": "2010-12",
      "completion_date": "2015-03",
      "enrollment": 0,
      "sponsor": "Vericel Corporation"
    },
    {
      "nct_id": "NCT00797550",
      "title": "Use of TRC Autologous Bone Marrow Cells in Posterolateral Lumbar Spine Fusion",
      "status": "TERMINATED",
      "phase": "PHASE1, PHASE2",
      "condition": "Single Level Posterolateral Spinal Fusion",
      "start_date": "2006-04",
      "completion_date": "2008-10",
      "enrollment": 0,
      "sponsor": "Vericel Corporation"
    },
    {
      "nct_id": "NCT06915233",
      "title": "A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Chondral Defect, Articular Cartilage Defect",
      "start_date": "2025-12",
      "completion_date": "2030-07",
      "enrollment": 0,
      "sponsor": "Vericel Corporation"
    }
  ],
  "summary": {
    "total_trials": 15,
    "by_phase": {
      "PHASE2": 4,
      "PHASE3": 5,
      "PHASE4": 1,
      "PHASE1, PHASE2": 3,
      "": 2
    },
    "by_status": {
      "COMPLETED": 11,
      "TERMINATED": 2,
      "RECRUITING": 2
    },
    "active_trials": 2,
    "completed_trials": 11,
    "conditions": [
      "Alveolar Bone Loss",
      "Articular Cartilage",
      "Articular Cartilage Defect",
      "Articular Cartilage Defects",
      "Articular Cartilage, Cartilage Diseases",
      "Chondral Defect, Articular Cartilage Defect",
      "Chondral Defect, Osteochondritis Dissecans (OCD), Articular Cartilage Defect, Articular Cartilage Disorder of Knee",
      "Critical Limb Ischemia",
      "Dilated Cardiomyopathy",
      "Fracture, Ununited, Pseudarthrosis",
      "Ischemic Dilated Cardiomyopathy (IDCM)",
      "Osteonecrosis",
      "Peripheral Arterial Disease",
      "Single Level Posterolateral Spinal Fusion"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:22:43.537348",
    "search_query": "Vericel Corporation",
    "url": "https://clinicaltrials.gov/search?term=Vericel+Corporation"
  }
}